Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs
Authors
Keywords
Osteosarcoma, Cancer immunotherapy, PD-1, PD-L1, Tumor immune microenvironment
Journal
CANCER LETTERS
Volume 500, Issue -, Pages 1-10
Publisher
Elsevier BV
Online
2020-12-23
DOI
10.1016/j.canlet.2020.12.024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- MicroRNA-200a induces immunosuppression by promoting PTEN-mediated PD-L1 upregulation in osteosarcoma
- (2020) Zhuochao Liu et al. Aging-US
- Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
- (2020) Kazushige Yoshida et al. BMC CANCER
- Bone sarcomas in the immunotherapy era
- (2020) Marie‐Françoise Heymann et al. BRITISH JOURNAL OF PHARMACOLOGY
- Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
- (2020) Zhidong Wang et al. Frontiers in Immunology
- Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+conventional dendritic cells
- (2020) Yifan Zhou et al. Journal for ImmunoTherapy of Cancer
- Novel Oncolytic Virus Armed with Cancer Suicide Gene and Normal Vasculogenic Gene for Improved Anti-Tumor Activity
- (2020) Su-Nam Jeong et al. Cancers
- Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients
- (2020) Jun Wang et al. JOURNAL OF NANOBIOTECHNOLOGY
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Current and Emerging Targets in Immunotherapy for Osteosarcoma
- (2019) Shinji Miwa et al. Journal of Oncology
- Osteosarcoma cell intrinsic PD-L2 signals promote invasion and metastasis via the RhoA-ROCK-LIMK2 and autophagy pathways
- (2019) Tingting Ren et al. Cell Death & Disease
- Nanoparticle enhanced MRI can monitor macrophage response to CD47 mAb immunotherapy in osteosarcoma
- (2019) Suchismita Mohanty et al. Cell Death & Disease
- Positron Emission Tomography Detects In Vivo Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma
- (2019) Elizabeth R Butch et al. CANCER RESEARCH
- miR‐134 inhibits osteosarcoma cell invasion and metastasis through targeting MMP 1 and MMP 3 in vitro and in vivo
- (2019) Cheng‐long Chen et al. FEBS LETTERS
- Anti-CD166/4-1BB chimeric antigen receptor T cell therapy for the treatment of osteosarcoma
- (2019) Yitian Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Clinical Efficacy and Complication Rate of Sunitinib 2/1 Versus 4/2 Schedule for the Treatment of Metastatic Renal Cell Cancer: A Systematic Review and Meta-Analysis
- (2019) Chenglong Chen et al. Clinical Genitourinary Cancer
- Emerging trends in immunotherapy for pediatric sarcomas
- (2019) Kyle A. Dyson et al. Journal of Hematology & Oncology
- Advances in immune checkpoint inhibitors for bone sarcoma therapy
- (2019) Pichaya Thanindratarn et al. Journal of Bone Oncology
- Tumour-Derived Extracellular Vesicles (EVs): A Dangerous “Message in A Bottle” for Bone
- (2019) Alfredo Cappariello et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- The tetraspanin CD81 mediates the growth and metastases of human osteosarcoma
- (2019) Naoki Mizoshiri et al. CELLULAR ONCOLOGY
- Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
- (2019) Jingzhe Zhang et al. Journal of Bone Oncology
- SDF-1/CXCR4 axis facilitates myeloid-derived suppressor cells accumulation in osteosarcoma microenvironment and blunts the response to anti-PD-1 therapy
- (2019) Kuo Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3
- (2018) Bingxin Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HER4 promotes cell survival and chemoresistance in osteosarcoma via interaction with NDRG1
- (2018) Hongsheng Wang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma
- (2018) Binghao Li et al. CANCER RESEARCH
- PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse
- (2018) Bingxin Zheng et al. Journal of Hematology & Oncology
- Association of anti-HER2 antibody with graphene oxide for curative treatment of osteosarcoma
- (2018) Lan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Immunotherapy for osteosarcoma: Where do we go from here?
- (2018) Mary F. Wedekind et al. PEDIATRIC BLOOD & CANCER
- MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
- (2018) Scott J. Rodig et al. Science Translational Medicine
- Anti-PD-1 therapy redirects macrophages from an M2 to an M1 phenotype inducing regression of OS lung metastases
- (2018) Pooja Dhupkar et al. Cancer Medicine
- Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis
- (2018) Zhan Wang et al. Frontiers in Immunology
- Epacadostat Plus Pembrolizumab in Patients With Advanced Solid Tumors: Phase I Results From a Multicenter, Open-Label Phase I/II Trial (ECHO-202/KEYNOTE-037)
- (2018) Tara C. Mitchell et al. JOURNAL OF CLINICAL ONCOLOGY
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis
- (2018) Yu Han et al. CANCER LETTERS
- Macrophage-derived IL-1β and TNF-α regulate arginine metabolism in neuroblastoma
- (2018) Livingstone Fultang et al. CANCER RESEARCH
- Humanized 3F8 Anti-GD2 Monoclonal Antibody Dosing With Granulocyte-Macrophage Colony-Stimulating Factor in Patients With Resistant Neuroblastoma
- (2018) Brian H. Kushner et al. JAMA Oncology
- Autophagy inhibitor enhance ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing PD-L1 expression in osteosarcoma immunotherapy
- (2018) Wei Yu et al. BIOMATERIALS
- Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells
- (2017) Ryan M. Troyer et al. EXPERIMENTAL CELL RESEARCH
- Current and future therapeutic approaches for osteosarcoma
- (2017) Douglas J. Harrison et al. Expert Review of Anticancer Therapy
- Primary metastatic osteosarcoma: results of a prospective study in children given chemotherapy and interleukin-2
- (2017) Cristina Meazza et al. MEDICAL ONCOLOGY
- Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
- (2017) Sattva S. Neelapu et al. Nature Reviews Clinical Oncology
- Targeting the PD-1 pathway in pediatric solid tumors and brain tumors
- (2017) Lars Wagner et al. OncoTargets and Therapy
- Cancer associated fibroblasts: An essential role in the tumor microenvironment
- (2017) Leilei Tao et al. Oncology Letters
- Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells
- (2017) Juliane Gust et al. Cancer Discovery
- All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages
- (2017) Qian Zhou et al. Cancer Immunology Research
- Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis
- (2017) Simin Kiany et al. OncoImmunology
- Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies
- (2016) Chuang Sun et al. BLOOD
- Immunotherapy with a HER2-Targeting Listeria Induces HER2-Specific Immunity and Demonstrates Potential Therapeutic Effects in a Phase I Trial in Canine Osteosarcoma
- (2016) N. J. Mason et al. CLINICAL CANCER RESEARCH
- Progress and opportunities for immune therapeutics in osteosarcoma
- (2016) Christina K Lettieri et al. Immunotherapy
- T-Cell Therapy Using Interleukin-21–Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor Regression
- (2016) Aude G. Chapuis et al. JOURNAL OF CLINICAL ONCOLOGY
- The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma
- (2016) Ling Wang et al. TUMOR BIOLOGY
- Dendritic cells combined with doxorubicin induces immunogenic cell death and exhibits antitumor effects for osteosarcoma
- (2016) MASANORI KAWANO et al. Oncology Letters
- T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities
- (2016) Zhan Wang et al. Frontiers in Immunology
- TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
- (2016) Audrey Lamora et al. Journal of Clinical Medicine
- Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
- (2016) Pratistha Koirala et al. Scientific Reports
- Bone microenvironment signals in osteosarcoma development
- (2015) Arantzazu Alfranca et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors
- (2015) M. S. Merchant et al. CLINICAL CANCER RESEARCH
- Immunotherapeutic Approaches to Sarcoma
- (2015) Melissa Burgess et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Expression of B7-H3 in cancer tissue during osteosarcoma progression in nude mice
- (2015) S.J. Yin et al. GENETICS AND MOLECULAR RESEARCH
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells
- (2015) Augusta Jamin et al. JOURNAL OF VIROLOGY
- T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
- (2015) Daniel W Lee et al. LANCET
- Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism
- (2015) C Krupka et al. LEUKEMIA
- Combination cancer immunotherapy and new immunomodulatory targets
- (2015) Kathleen M. Mahoney et al. NATURE REVIEWS DRUG DISCOVERY
- Dendritic cells combined with anti-GITR antibody produce antitumor effects in osteosarcoma
- (2015) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Adoptive cell transfer as personalized immunotherapy for human cancer
- (2015) S. A. Rosenberg et al. SCIENCE
- Exosomes and their roles in immune regulation and cancer
- (2015) David W. Greening et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models
- (2015) Ji-Feng Xu et al. Oncotarget
- Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma
- (2015) Danielle M Lussier et al. Journal for ImmunoTherapy of Cancer
- Increased CTLA-4+ T cells and an increased ratio of monocytes with loss of class II (CD14+ HLA-DRlo/neg) found in aggressive pediatric sarcoma patients
- (2015) Pooja Hingorani et al. Journal for ImmunoTherapy of Cancer
- Immunotherapy of Childhood Sarcomas
- (2015) Stephen S. Roberts et al. Frontiers in Oncology
- Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma
- (2015) Binghao Li et al. Oncotarget
- Preclinical Evidence That PD1 Blockade Cooperates with Cancer Vaccine TEGVAX to Elicit Regression of Established Tumors
- (2014) J. Fu et al. CANCER RESEARCH
- Comprehensive Evaluation of the Cytotoxic T-Lymphocyte Antigen-4 Gene Polymorphisms in Risk of Bone Sarcoma
- (2014) Shouying Liu et al. Genetic Testing and Molecular Biomarkers
- Interleukin-34 promotes tumor progression and metastatic process in osteosarcoma through induction of angiogenesis and macrophage recruitment
- (2014) Aude I. Ségaliny et al. INTERNATIONAL JOURNAL OF CANCER
- Going back to class I: MHC and immunotherapies for childhood cancer
- (2014) Kellie B. Haworth et al. PEDIATRIC BLOOD & CANCER
- Prostate Tumor-Derived Exosomes Down-Regulate NKG2D Expression on Natural Killer Cells and CD8+ T Cells: Mechanism of Immune Evasion
- (2014) Marie Lundholm et al. PLoS One
- Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
- (2014) M. L. Davila et al. Science Translational Medicine
- IDO is highly expressed in breast cancer and breast cancer-derived circulating microvesicles and associated to aggressive types of tumors by in silico analysis
- (2014) M. T. Isla Larrain et al. TUMOR BIOLOGY
- Programmed Cell Death Ligand 1 Expression in Osteosarcoma
- (2014) J. K. Shen et al. Cancer Immunology Research
- T Lymphocytes Expressing a CD16 Signaling Receptor Exert Antibody-Dependent Cancer Cell Killing
- (2013) K. Kudo et al. CANCER RESEARCH
- Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma
- (2013) MASANORI KAWANO et al. ONCOLOGY REPORTS
- Natural killer cell therapy and aerosol interleukin-2 for the treatment of osteosarcoma lung metastasis
- (2013) Sergei R. Guma et al. PEDIATRIC BLOOD & CANCER
- CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
- (2013) R. J. Brentjens et al. Science Translational Medicine
- Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors
- (2013) Fengbin Yu et al. TUMOR BIOLOGY
- Effect of the cytokine levels in serum on osteosarcoma
- (2013) Hong Xiao et al. TUMOR BIOLOGY
- Anti-TGF-β Antibody Combined with Dendritic Cells Produce Antitumor Effects in Osteosarcoma
- (2012) Masanori Kawano et al. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
- A novel recombinant immunocasp-6 fusion gene specifically and efficiently suppresses HER2-overexpressing osteosarcoma
- (2012) BEN-GEN ZHOU et al. ONCOLOGY REPORTS
- Immunotherapy targeting HER2 with genetically modified T cells eliminates tumor-initiating cells in osteosarcoma
- (2011) N Rainusso et al. CANCER GENE THERAPY
- Genetically Modified T cells Targeting Interleukin-11 Receptor -Chain Kill Human Osteosarcoma Cells and Induce the Regression of Established Osteosarcoma Lung Metastases
- (2011) G. Huang et al. CANCER RESEARCH
- Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents
- (2011) E. P. Buddingh et al. CLINICAL CANCER RESEARCH
- Combination of lentivector immunization and low-dose chemotherapy or PD-1/PD-L1 blocking primes self-reactive T cells and induces anti-tumor immunity
- (2011) Sophie R. Sierro et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IFN-γ enhances HOS and U2OS cell lines susceptibility to γδ T cell-mediated killing through the Fas/Fas ligand pathway
- (2011) Zhaoxu Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- (2011) Paul F. Robbins et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response
- (2010) J. Dong et al. MOLECULAR CANCER THERAPEUTICS
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
- (2010) Alice L. Yu et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors
- (2010) M. A. Curran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Caspase-6 and Anti-HER2 Antibody Chimeric Tumor-Targeted Proapoptotic Molecule Decreased Metastasis of Human Osteosarcoma
- (2009) Li-Feng Wang et al. CANCER INVESTIGATION
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- Immunotherapy with Interleukin-18 in Combination with Preoperative Chemotherapy with Ifosfamide Effectively Inhibits Postoperative Progression of Pulmonary Metastases in a Mouse Osteosarcoma Model
- (2009) Naoko Yamada et al. TUMOR BIOLOGY
- A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas
- (2008) C. L. Mackall et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More